Processing math: 100%
Review

Possible roles of transglutaminases in molecular mechanisms responsible for human neurodegenerative diseases

  • Received: 18 October 2016 Accepted: 11 November 2016 Published: 15 November 2016
  • Transglutaminases are a family of Ca2+-dependent enzymes which catalyze post-translational modifications of proteins. The main activity of these enzymes is the cross-linking of glutaminyl residues of a protein/peptide substrate to lysyl residues of a protein/peptide co-substrate. In addition to lysyl residues, other second nucleophilic co-substrates may include monoamines or polyamines (to form mono- or bi-substituted/crosslinked adducts) or –OH groups (to form ester linkages). In absence of co-substrates, the nucleophile may be water, resulting in the net deamidation of the glutaminyl residue. Transglutaminase activity has been suggested to be involved in molecular mechanisms responsible for both physiological or pathological processes. In particular, transglutaminase activity has been shown to be responsible for human autoimmune diseases, Celiac Disease is just one of them. Interestingly, neurodegenerative diseases, such as Alzheimer’s Disease, Parkinson’s Disease, supranuclear palsy, Huntington’s Disease and other polyglutamine diseases, are characterized in part by aberrant cerebral transglutaminase activity and by increased cross-linked proteins in affected brains. This review describes the possible molecular mechanisms by which these enzymes could be responsible for such diseases and the possible use of transglutaminase inhibitors for patients with diseases characterized by aberrant transglutaminase activity.

    Citation: Nicola Gaetano Gatta, Gaetano Cammarota, Vittorio Gentile. Possible roles of transglutaminases in molecular mechanisms responsible for human neurodegenerative diseases[J]. AIMS Biophysics, 2016, 3(4): 529-545. doi: 10.3934/biophy.2016.4.529

    Related Papers:

    [1] Reinhard Racke . Blow-up for hyperbolized compressible Navier-Stokes equations. Communications in Analysis and Mechanics, 2025, 17(2): 550-581. doi: 10.3934/cam.2025022
    [2] Huiyang Xu . Existence and blow-up of solutions for finitely degenerate semilinear parabolic equations with singular potentials. Communications in Analysis and Mechanics, 2023, 15(2): 132-161. doi: 10.3934/cam.2023008
    [3] Yue Pang, Xiaotong Qiu, Runzhang Xu, Yanbing Yang . The Cauchy problem for general nonlinear wave equations with doubly dispersive. Communications in Analysis and Mechanics, 2024, 16(2): 416-430. doi: 10.3934/cam.2024019
    [4] Xiulan Wu, Yaxin Zhao, Xiaoxin Yang . On a singular parabolic $ p $-Laplacian equation with logarithmic nonlinearity. Communications in Analysis and Mechanics, 2024, 16(3): 528-553. doi: 10.3934/cam.2024025
    [5] Yuxuan Chen . Global dynamical behavior of solutions for finite degenerate fourth-order parabolic equations with mean curvature nonlinearity. Communications in Analysis and Mechanics, 2023, 15(4): 658-694. doi: 10.3934/cam.2023033
    [6] Tingfu Feng, Yan Dong, Kelei Zhang, Yan Zhu . Global existence and blow-up to coupled fourth-order parabolic systems arising from modeling epitaxial thin film growth. Communications in Analysis and Mechanics, 2025, 17(1): 263-289. doi: 10.3934/cam.2025011
    [7] Isaac Neal, Steve Shkoller, Vlad Vicol . A characteristics approach to shock formation in 2D Euler with azimuthal symmetry and entropy. Communications in Analysis and Mechanics, 2025, 17(1): 188-236. doi: 10.3934/cam.2025009
    [8] Mahmoud El Ahmadi, Mohammed Barghouthe, Anass Lamaizi, Mohammed Berrajaa . Existence and multiplicity results for a kind of double phase problems with mixed boundary value conditions. Communications in Analysis and Mechanics, 2024, 16(3): 509-527. doi: 10.3934/cam.2024024
    [9] Ming Liu, Binhua Feng . Grand weighted variable Herz-Morrey spaces estimate for some operators. Communications in Analysis and Mechanics, 2025, 17(1): 290-316. doi: 10.3934/cam.2025012
    [10] Yang Liu, Xiao Long, Li Zhang . Long-time dynamics for a coupled system modeling the oscillations of suspension bridges. Communications in Analysis and Mechanics, 2025, 17(1): 15-40. doi: 10.3934/cam.2025002
  • Transglutaminases are a family of Ca2+-dependent enzymes which catalyze post-translational modifications of proteins. The main activity of these enzymes is the cross-linking of glutaminyl residues of a protein/peptide substrate to lysyl residues of a protein/peptide co-substrate. In addition to lysyl residues, other second nucleophilic co-substrates may include monoamines or polyamines (to form mono- or bi-substituted/crosslinked adducts) or –OH groups (to form ester linkages). In absence of co-substrates, the nucleophile may be water, resulting in the net deamidation of the glutaminyl residue. Transglutaminase activity has been suggested to be involved in molecular mechanisms responsible for both physiological or pathological processes. In particular, transglutaminase activity has been shown to be responsible for human autoimmune diseases, Celiac Disease is just one of them. Interestingly, neurodegenerative diseases, such as Alzheimer’s Disease, Parkinson’s Disease, supranuclear palsy, Huntington’s Disease and other polyglutamine diseases, are characterized in part by aberrant cerebral transglutaminase activity and by increased cross-linked proteins in affected brains. This review describes the possible molecular mechanisms by which these enzymes could be responsible for such diseases and the possible use of transglutaminase inhibitors for patients with diseases characterized by aberrant transglutaminase activity.


    In this paper, we study the initial boundary value problem of the nonlinear viscoelastic hyperbolic problem with variable exponents:

    {utt+2u+2uttt0g(tτ)2u(τ)dτ+|ut|m(x)2ut=|u|p(x)2u,(x,t)Ω×(0,T),u(x,t)=uν(x,t)=0,(x,t)Ω×(0,T),u(x,0)=u0(x), ut(x,0)=u1(x),xΩ, (1.1)

    where ΩRn(n1) is a bounded domain in Rn with a smooth boundary Ω, ν is the unit outer normal to Ω, the exponents m(x) and p(x) are continuous functions on ¯Ω with the logarithmic module of continuity:

    x,yΩ,|xy|<1,|m(x)m(y)|+|p(x)p(y)|ω(|xy|), (1.2)

    where

    limτ0+supω(τ)ln1τ=C<. (1.3)

    In addition to this condition, the exponents satisfy the following:

    2m:=essinfxΩm(x)m(x)m+:=esssupxΩm(x)<2(n2)n4, (1.4)
    2p:=essinfxΩp(x)p(x)p+:=esssupxΩp(x)<2(n2)n4, (1.5)

    g:R+R+ is a C1 function satisfying

    g(0)>0, g(τ)0,10g(τ)dτ=l>0. (1.6)

    The equation of Problem (1.1) arises from the modeling of various physical phenomena such as the viscoelasticity and the system governing the longitudinal motion of a viscoelastic configuration obeying a nonlinear Boltzmann's model, or electro-rheological fluids, viscoelastic fluids, processes of filtration through a porous medium, and fluids with temperature-dependent viscosity and image processing which give rise to equations with nonstandard growth conditions, that is, equations with variable exponents of nonlinearities. More details on these problems can be found in previous studies [1,2,3,4,5,6].

    When m(x) and p(x) are constants, Messaoudi [7] discussed the nonlinear viscoelastic wave equation

    uttu+t0g(tτ)u(τ)dτ+|ut|m2ut=|u|p2u,

    he proved that any weak solution with negative initial energy blows up in finite time if p>m, and a global existence result for pm. The results were improved later by Messaoudi [8], where the blow-up result in finite time with positive initial energy was obtained. Moreover, Song [9] showed the finite-time blow-up of some solutions whose initial data had arbitrarily high initial energy. In the same year, Song [10] studied the initial-boundary value problem

    |ut|ρuttu+t0g(tτ)u(τ)dτ+|ut|m2ut=|u|p2u,

    and proved the nonexistence of global solutions with positive initial energy. Cavalcanti, Domingos, and Ferreira [11] were concerned with the non-linear viscoelastic equation

    |ut|ρuttuutt+t0g(tτ)u(τ)dτγut=0,

    and proved the global existence of weak solutions. Moreover, they obtained the uniform decay rates of the energy by assuming a strong damping ut acting in the domain and providing the relaxation function which decays exponentially.

    In 2017, Messaoudi [12] considered the following nonlinear wave equation with variable exponents:

    uttu+a|ut|m(x)2ut=b|u|p(x)2u,

    where a,b are positive constants. By using the FaedoGalerkin method, the existence of a unique weak solution is established under suitable assumptions on the variable exponents m(x) and p(x). Then this paper also proved the finite-time blow-up of solutions and gave a two-dimensional numerical example to illustrate the blow up result. Park [13] showed the blow up of solutions for a viscoelastic wave equation with variable exponents

    uttu+t0g(ts)u(s)ds+a|ut|m(x)2ut=b|u|p(x)2u,

    where the exponents of nonlinearity p(x) and m(x) are given functions and a,b>0 are constants. For nonincreasing positive function g, they prove the blow-up result for the solutions with positive initial energy as well as nonpositive initial energy. Alahyane [14] discussed the nonlinear viscoelastic wave equation with variable exponents

    uttu+t0g(tτ)u(τ)dτ+μut=|u|p(x)2u,

    where μ is a nonnegative constant and the exponent of nonlinearity p(x) and g are given functions. Under arbitrary positive initial energy and specific conditions on the relaxation function g, they prove a finite-time blow-up result and give some numerical applications to illustrate their theoretical results. Ouaoua and Boughamsa [15] considered the following boundary value problem:

    utt+2uu+|ut|m(x)2ut=|u|p(x)2u,

    the authors established the local existence by using the FaedoGalerkin method with positive initial energy and suitable conditions on the variable exponents m(x) and r(x). In addition, they also proved that the local solution is global and obtained the stability estimate of the solution. Ding and Zhou [16] considered a Timoshenko-type equation

    utt+2uM(||u||22)u+|ut|p(x)2ut=|u|q(x)2u,

    they prove that the solutions blow up in finite time with positive initial energy. Therefore, the existence of finite-time blow-up solutions with arbitrarily high initial energy is established, and the upper and lower bounds of the blow-up time are derived. More related references can be found in [17,18,19,20,21,22].

    Motivated by [7,13,14], we considered the existence of the solutions and their blow-up for the nonlinear damping and viscoelastic hyperbolic problem with variable exponents. Our aim in this work is to prove the existence of the weak solutions and to find sufficient conditions on m(x) and p(x) for which the blow-up takes place.

    This article consists of three sections in addition to the introduction. In Section 2, we recall the definitions and properties of Lp(x)(Ω) and the Sobolev spaces W1,p(x)(Ω). In Section 3, we prove the existence of weak solutions for Problem (1.1). In Section 4, we state and prove the blow-up result for solutions with positive initial energy as well as nonpositive initial energy.

    In this section, we review some results regarding Lebesgue and Sobolev spaces with variable exponents first. All of these results and a comprehensive study of these spaces can be found in [23]. Here (,) and , denote the inner product in space L2(Ω) and the duality pairing between H2(Ω) and H20(Ω).

    The variable exponent Lebesgue space Lp(x)(Ω) is defined by

    Lp(x)(Ω)={u(x):uismeasurableinΩ, ρp(x)(u)=Ω|u|p(x)dx<},

    this space is endowed with the norm

    up(x)=inf {λ>0:Ω|u(x)λ|p(x)dx1}.

    The variable exponent Sobolev space W1,p(x)(Ω) is defined by

    W1,p(x)(Ω)={uLp(x)(Ω) suchthatuexistsand|u|Lp(x)(Ω)},

    the corresponding norm for this space is

    u1,p(x)=up(x)+up(x),

    define W1,p(x)0(Ω) as the closure of  C0(Ω) with respect to the W1,p(x)(Ω) norm. The spaces  Lp(x)(Ω),W1,p(x)(Ω) and W1,p(x)0(Ω) are separable and reflexive Banach spaces when 1<pp+<, where p:=essinfΩp(x) and p+:=esssupΩp(x). As usual, we denote the conjugate exponent of p(x) by p(x)=p(x)/(p(x)1) and the Sobolev exponent by

    p(x)={np(x)nkp(x),if p(x)<n,,if p(x)n.

    Lemma 2.1. If p1(x), p2(x)C+(¯Ω)={hC(¯Ω):minx¯Ωh(x)>1}, p1(x)p2(x) for any xΩ, then there exists the continuous embedding Lp2(x)(Ω)Lp1(x)(Ω), whose norm does not exceed |Ω|+1.

    Lemma 2.2. Let p(x), q(x)C+(¯Ω). Assuming that q(x)<p(x), there is a compact and continuous embedding Wk,p(x)(Ω)Lq(x)(Ω).

    Lemma 2.3. (Hölder's inequality) [24] For any uLp(x)(Ω) and vLq(x)(Ω), then the following inequality holds:

    |Ωuvdx|(1p+1q)||u||p(x)||v||q(x)2||u||p(x)||v||q(x).

    Lemma 2.4. For uLp(x)(Ω), the following relations hold:

    u0(up(x)=λρp(x)(uλ)=1),
    up(x)<1(=1;>1)ρp(x)(u)<1(=1;>1),
    up(x)>1upp(x)ρp(x)(u)up+p(x),
    up(x)<1up+p(x)ρp(x)(u)upp(x).

    Next, we give the definition of the weak solution to Problem (1.1).

    Definition 2.1. A function u(x, t) is called a weak solution for Problem (1.1), if uC(0,T;H20(Ω)) C1(0,T;H20(Ω))C2(0,T;H2(Ω)) with uttL2(0,T;H20(Ω)) and u satisfies the following conditions:

    (1) For every ωH20(Ω) and for a.e.t(0,T)

    utt,ω+(u,ω)+(utt,ω)t0g(tτ)(u(τ),ω)dτ+(|ut|m(x)2ut,ω)=(|u|p(x)2u,ω),

    (2) u(x,0)=u0(x)H20(Ω),ut(x,0)=u1(x)H20(Ω).

    In this section, we prove the existence of a weak solution for Problem (1.1) by making use of the Faedo–Galerkin method and the contraction mapping principle. For a fixed T>0, we consider the space H=C(0,T;H20(Ω))C1(0,T;H20(Ω)) with the norm ||v||2H=max0tT(||vt||22+l||v||22).

    Lemma 3.1. Assume that (1.4), (1.5), and (1.6) hold, let (u0,u1)H20(Ω)×H20(Ω), for any T>0, vH, then there exists uC(0,T;H20(Ω))C1(0,T;H20(Ω))C2(0,T;H2(Ω)) with  uttL2(0,T;H20(Ω)) satisfying

    {utt+2u+2uttt0g(tτ)2u(τ)dτ+|ut|m(x)2ut=|v|p(x)2v,(x,t)Ω×(0,T),u(x,t)=uν(x,t)=0,(x,t)Ω×(0,T),u(x,0)=u0(x), ut(x,0)=u1(x),xΩ. (3.1)

    Proof. Let {ωj}j=1 be the orthogonal basis of H20(Ω), which is the standard orthogonal basis in L2(Ω) such that

    ωj=λjωj  in  Ω,ωj=0  on  Ω,

    we denote by Vk=span{ω1,ω2,,ωk} the subspace generated by the first k vectors of the basis {ωj}j=1. By normalization, we have ||ωj||2=1. For all k1, we seek k functions ck1(t),ck2(t),,ckk(t)C2[0,T] such that

    uk(x,t)=kj=1ckj(t)ωj(x),

    satisfying the following approximate problem

    {(uktt,ωi)+(uk,ωi)+(uktt,ωi)t0g(tτ)(uk,ωi)dτ+(|ukt|m(x)2ukt,ωi)=Ω|v|p(x)2vωidx,uk(0)=uk0,   ukt(0)=uk1,     i=1,2,k, (3.2)

    where

    uk0=ki=1(u0,ωi)ωiu0   in  H20(Ω),
    uk1=ki=1(u1,ωi)ωiu1   in  H20(Ω),

    thus, (3.2) generates the initial value problem for the system of second-order differential equations with respect to cki(t):

    {(1+λ2i)ckitt(t)+λ2icki(t)=Gi(ck1t(t),,ckkt(t))+gi(cki(t)),   i=1,2,,k,cki(0)=Ωu0ωidx,      ckit(0)=Ωu1ωidx,              i=1,2,,k. (3.3)

    where

    Gi(ck1t(t),,ckkt(t))=Ω|kj=1ckjt(t)ωj(x)|m(x)2kj=1ckjt(t)ωj(x)ωi(x)dx,

    and

    gi(cki(t))=λ2it0g(tτ)cki(τ)dτ+Ω|v|p(x)2vωidx,

    by Peano's Theorem, we infer that the Problem (3.3) admits a local solution cki(t)C2[0,T].

    The first estimate. Multiplying (3.2) by ckit(t) and summing with respect to i, we arrive at the relation

    ddt(12||ukt||22+12||uk||22+12||ukt||22)+Ω|ukt|m(x)dxt0g(tτ)Ωuk(τ)uktdxdτ=Ω|v|p(x)2vuktdx. (3.4)

    By simple calculation, we have

    t0g(tτ)ΩΔuk(τ)Δuktdxdτ=12ddt(guk)12(guk)12ddtt0g(τ)dτ||Δuk||22+12g(t)||uk||22, (3.5)

    where

    (φψ)=t0φ(tτ)||ψ(t)ψ(τ)||22dτ,

    inserting (3.5) into (3.4), using Hölder's inequality and Young's inequality, we obtain

    ddt[12||ukt||22+12||ukt||22+12(guk)+12(1t0g(τ)dτ)||Δuk||22]=12(guk)12g(t)||uk||22+Ω|v|p(x)2vuktdxΩ|ukt|m(x)dxΩ|v|p(x)2vuktdx|v|p(x)2v2||ukt||2η2Ω|v|2(p(x)1)dx+12η||ukt||22, (3.6)

    using the embedding H20(Ω)L2(p(x)1)(Ω) and Lemma 2.4, we easily obtain

    Ω|v|2(p(x)1)dxmax{||v||2(p1)2(p(x)1),||v||2(p+1)2(p(x)1)}Cmax{||v||2(p1)2,||v||2(p+1)2}C, (3.7)

    where C is a positive constant. We denote by C various positive constants that may be different at different occurrences.

    Combining (3.6) and (3.7), we obtain

    ddt[12||ukt||22+12||ukt||22+12(guk)+12(1t0g(τ)dτ)||Δuk||22]η2C+12η||ukt||22,

    by Gronwall's inequality, there exists a positive constant CT such that

    ||ukt||22+||ukt||22+(guk)+l||Δuk||22CT, (3.8)

    therefore, there exists a subsequence of {uk}k=1, which we still denote by {uk}k=1, such that

    uku weakly star in L(0,T;H20(Ω)),uktut weakly star in L(0,T;H20(Ω)),uku weakly in L2(0,T;H20(Ω)),uktut weakly in L2(0,T;H20(Ω)). (3.9)

    The second estimate. Multiplying (3.2) by ckitt(t) and summing with respect to i, we obtain

    ||uktt||22+||Δuktt||22+ddt(Ω1m(x)|ukt|m(x)dx)=Ωukukttdx+t0g(tτ)ΩΔuk(τ)Δukttdxdτ+Ω|v|p(x)2vukttdx. (3.10)

    Note that we have the estimates for ε>0

    |Ωukukttdx|ε||uktt||22+14ε||uk||22, (3.11)
    Ω|v|p(x)2vukttdx|v|p(x)2v2uktt2ε||uktt||22+14εΩ|v|2(p(x)1)dx, (3.12)

    and

    |t0g(tτ)Ωuk(τ)ukttdxdτ|14εΩ(t0g(tτ)uk(τ)dτ)2dx+ε||uktt||22ε||uktt||22+14εt0g(s)dst0g(tτ)Ω|uk(τ)|2dxdτε||uktt||22+(1l)g(0)4εt0||uk(τ)||22dτ, (3.13)

    similar to (3.6) and (3.7), from H20(Ω)L2(Ω), we have

    Ω|v|p(x)2vukttdxεC||uktt||22+C4ε. (3.14)

    Taking into account (3.10)(3.14), we obtain

    ||uktt||22+(12εCε)||uktt||22+ddt(Ω1m(x)|ukt|m(x)dx)14ε||uk||22+(1l)g(0)4εt0||uk(τ)||22dτ+C4ε, (3.15)

    integrating (3.15) over (0,t), we obtain

    t0||uktt||22dτ+(12εCε)t0||uktt||22dτ+Ω1m(x)|ukt|m(x)dxC4εt0(||uk||22+τ0||uk(s)||22ds)dτ+CT, (3.16)

    taking ε small enough in (3.16), for some positive constant CT, we obtain

    t0||uktt||22dτ+t0||uktt||22dτCT, (3.17)

    we observe that estimate (3.17) implies that there exists a subsequence of {uk}k=1, which we still denote by {uk}k=1, such that

    ukttutt weakly in L2(0,T;H20(Ω)). (3.18)

    In addition, from (3.9), we have

    (uktt,ωi)=ddt(ukt,ωi)ddt(ut,ωi)=(utt,ωi)  weakly  star  in  L(0,T;H2(Ω)). (3.19)

    Next, we will deal with the nonlinear term. Combining (3.9), (3.18), and Aubin–Lions theorem [25], we deduce that there exists a subsequence of {uk}k=1 such that

    uktut strongly in C(0,T;L2(Ω)), (3.20)

    then

    |ukt|m(x)2ukt|ut|m(x)2ut  a.e. (x,t)Ω×(0,T), (3.21)

    using the embedding H20(Ω)L2(m(x)1)(Ω) and Lemma 2.4, we have

    |ukt|m(x)2ukt22=Ω|ukt|2(m(x)1)dxmax{||ukt||2(m1)2,||ukt||2(m+1)2}C, (3.22)

    hence, using (3.21) and (3.22), we obtain

    |ukt|m(x)2ukt|ut|m(x)2ut  weakly  star in L(0,T;L2(Ω)). (3.23)

    Setting up k in (3.2), combining with (3.9), (3.18), (3.19), and (3.23), we obtain

    utt,ω+(u,ω)+(utt,ω)t0g(tτ)(u(τ),ω)dτ+(|ut|m(x)2ut,ω)=(|v|p(x)2v,ω).

    To handle the initial conditions. From (3.9) and Aubin–Lions theorem, we can easily get uku in C(0,T;L2(Ω)), thus uk(0)u(0) in L2(Ω), and we also have that uk(0)=uk0u0 in H20(Ω), hence u(0)=u0 in H20(Ω). Similarly, we get that ut(0)=u1.

    Uniqueness. Suppose that (3.1) has solutions u and z, then ω=uz satisfies

    {ωtt+2ω+2ωttt0g(tτ)2ω(τ)dτ+|ut|m(x)2ut|zt|m(x)2zt=0,(x,t)Ω×(0,T),ω(x,t)=ων(x,t)=0,(x,t)Ω×(0,T),ω(x,0)=0, ωt(x,0)=0,xΩ.

    Multiplying the first equation of Problem (3.1) by ωt and integrating over Ω, we have

    12ddt[||ωt||22+(1t0g(τ)dτ)||ω||22+||ωt||22+(gω)]+12g(t)||ω||22=Ω(|ut|m(x)2ut|zt|m(x)2zt)(utzt)dx+12(gω),

    from the inequality

    (|a|m(x)2a|b|m(x)2b)(ab)0, (3.24)

    for all a,bRn and a.e. xΩ, we obtain

    ||ωt||22+l||ω||22+||ωt||22=0,

    which implies that ω=0. This completes the proof.

    Theorem 3.1. Assume that (1.4) and (1.6) hold, let the initial date (u0,u1)H20(Ω)×H20(Ω), and

    2pp(x)p+2(n3)n4,

    then there exists a unique local solution of Problem (1.1).

    Proof. For any T>0, consider MT={uH:u(0)=u0,ut(0)=u1,||u||HM}. Lemma 3.1 implies that for vMT, there exists u=S(v) such that u is the unique solution to Problem 3.1. Next, we prove that for a suitable T>0, S is a contractive map satisfying S(MT)MT.

    Multiplying the first equation of the Problem (3.1) by ut and integrating it over (0,t), we obtain

    ||ut||22+||ut||22+(gu)+l||Δu||22||u1||22+||u1||22+||Δu0||22+2t0Ω|v|p(x)2vutdxdτ, (3.25)

    using Hölder's inequality and Young's inequality, we have

    |Ω|v|p(x)2vutdx|γ||ut||22+14γΩ|v|2p(x)2dxγ||ut||22+14γ[Ω|v|2p2dx+Ω|v|2p+2dx]γ||ut||22+C4γ[||v||2p22+||v||2p+22],

    thus, (3.25) becomes

    ||ut||22+||ut||22+l||Δu||22λ0+2t0Ω|v|p(x)2vutdxdτλ0+2γTsup(0,T)||ut||22+TC2γsup(0,T)[||v||2p22+||v||2p+22],

    hence, we have

    sup(0,T)||ut||22+sup(0,T)||ut||22+lsup(0,T)||Δu||22λ0+2γTsup(0,T)||ut||22+TC2γsup(0,T)[||v||2p2H+||v||2p+2H],

    where λ0=||u1||22+||u1||22+||Δu0||22, choosing γ=12T such that

    ||u||2Hλ0+T2Csup(0,T)[||v||2p2H+||v||2p+2H].

    For any vMT, by choosing M large enough so that

    ||u||2Hλ0+2T2CM2(p+1)M2,

    and T>0, sufficiently small so that

    TM2λ02CM2(p+1),

    we obtain ||u||HM, which shows that S(MT)MT.

    Let v1,v2MT,u1=S(v1),u2=S(v2),u=u1u2, then u satisfies

    {utt+2u+2uttt0g(tτ)2u(τ)dτ+|u1t|m(x)2u1t|u2t|m(x)2u2t=|v1|p(x)2v1|v2|p(x)2v2,(x,t)Ω×(0,T),u(x,t)=uν(x,t)=0,(x,t)Ω×(0,T),u(x,0)=0, ut(x,0)=0,xΩ.

    Multiplying by ut and integrating over Ω×(0,t), we obtain

    12||ut||22+12(1t0g(τ)dτ)||u||22+12||ut||22+12(gu)+t0Ω[|u1t|m(x)2u1t|u2t|m(x)2u2t](u1tu2t)dxdτt0Ω(f(v1)f(v2))utdxdτ, (3.26)

    where f(v)=|v|p(x)2v. From (1.6) and (3.24), we obtain

    12||ut||22+l2||u||22+12||ut||22+12(gu)t0Ω(f(v1)f(v2))utdxdτ. (3.27)

    Now, we evaluate

    I=Ω|(f(v1)f(v2))||ut|dx=Ω|f(ξ)||v||ut|dx,

    where v=v1v2 and ξ=αv1+(1α)v2, 0α1. Thanks to Young's inequality and Hölder's inequality, we have

    Iδ2||ut||22+12δΩ|f(ξ)|2|v|2dxδ2||ut||22+(p+1)22δΩ|ξ|2(p(x)2)|v|2dxδ2||ut||22+(p+1)22δ(Ω|v|2nn2dx)n2n[Ω|ξ|n(p(x)2)dx]2nδ2||ut||22+(p+1)22δ(Ω|v|2nn2dx)n2n[(Ω|ξ|n(p+2)dx)2n+(Ω|ξ|n(p2)dx)2n]δ2||ut||22+(p+1)2C2δ||Δv||22[||ξ||2(p+2)2+||ξ||2(p2)2]δ2||ut||22+(p+1)2C2δ||Δv||22(M2(p+2)+M2(p2)). (3.28)

    Inserting (3.28) into (3.27), choosing δ small enough, we obtain

    ||u||2H(p+1)2CTδ(M2(p2)+M2(p+2))||v||2H,

    taking T small enough so that (p+1)2CTδ(M2(p2)+M2(p+2))<1, we conclude

    ||u||2H=||S(v1)S(v2)||2H||v1v2||2H,

    thus, the contraction mapping principle ensures the existence of a weak solution to Problem (1.1). This completes the proof.

    In this section, we show that the solution to Problem (1.1) blows up in finite time when the initial energy lies in positive as well as nonpositive. For this task, we define

    E(t)=12||ut||22+12(1t0g(τ)dτ)||u||22+12||ut||22+12(gu)Ω1p(x)|u|p(x)dx, (4.1)

    by the definition of E(t), we also have

    E(t)=Ω|ut|m(x)dx+12(gu)12g(t)||u||220. (4.2)

    Now, we set

    B1=max{1,Bl12},  λ1=(B21)2p2,  E1=(121p)(B21)pp2,

    and

    H(t)=E2E(t), (4.3)

    where the constant E2(E(0),E1) will be discussed later, and B is the best constant of the Sobolev embedding H20(Ω)Lp(x)(Ω). It follows from (4.2) that

    H(t)=E(t)0, (4.4)

    and H(t) is a nondecreasing function.

    To prove Theorem 4.1, we need the following two lemmas:

    Lemma 4.1. Suppose that (1.6) holds and the exponents m(x) and p(x) satisfy condition (1.4) and (1.5). Assume further that

    E(0)<E1  and  λ1<λ(0)=B21l||u0||22,

    then there exists a constant λ2>λ1 such that

    B21l||u||22λ2,  t0. (4.5)

    Proof. Using (1.6), (4.1), Lemma 2.4, and the embedding H20(Ω)Lp(x)(Ω), we find that

    E(t)12(1t0g(τ)dτ)||u||22Ω1p(x)|u|p(x)dxl2||u||221pΩ|u|p(x)dxl2||u||221pmax{||u||pp(x),||u||p+p(x)}l2||u||221pmax{Bp||u||p2,Bp+||u||p+2}l2||u||221pmax{Bp1lp2||u||p2,Bp+1lp+2||u||p+2}12B21λ1pmax{λp2,λp+2}:=G(λ), (4.6)

    where λ:=λ(t)=B21l||u||22. Analyzing directly the properties of G(λ), we deduce that G(λ) satisfies the following properties:

    G(λ)={12B21p+2pλp+22<0,  λ>1,12B2112λp22, 0<λ<1, 
    G+(1)=12B21p+2p<0,  G(1)=12B2112<0,
    G(λ1)=0,    0<λ1<1.

    It is easily verified that G(λ) is strictly increasing for 0<λ<λ1, strictly decreasing for λ1<λ, G(λ) as λ+, and G(λ1)=E1. Since E(0)<E1, there exists a λ2>λ1 such that G(λ2)=E(0). By (4.6), we see that G(λ(0))E(0)=G(λ2), which implies λ(0)λ2 since the condition λ(0)>λ1. To prove (4.5), we suppose by contradiction that for some t0>0, λt0=B21l||u(t0)||22<λ2. The continuity of B21l||u||22 illustrates that we could choose t0 such that λ1<λt0<λ2, then we have E(0)=G(λ2)<G(λt0)E(t0). This is a contradiction. The proof is completed.

    Lemma 4.2. Let the assumption in Lemma 4.1 be satisfied. For t[0,T), we have

    0<H(0)H(t)1pρp(x)(u).

    Proof. (4.4) indicates that H(t) is nondecreasing with respect to t, thus

    H(t)H(0)=E2E(0)>0,  t[0,T).

    It follows from (1.6), (4.1), and Lemma 4.1 that

    H(t)=E2E(t)=E212||ut||2212(1t0g(τ)dτ)||u||2212(gu)12||ut||22+Ω1p(x)|u|p(x)dxE1l2||u||22+Ω1p(x)|u|p(x)dxE112B21λ2+Ω1p(x)|u|p(x)dxE112B21λ1+Ω1p(x)|u|p(x)dxΩ1p(x)|u|p(x)dx1pρp(x)(u).

    The proof is completed.

    Our blow-up result reads as follows:

    Theorem 4.3. Suppose that

    2mm(x)m+<pp(x)p+2(n3)n4,

    and

    1l=0g(τ)dτ<p21p21+12p, (4.7)

    hold, if the following conditions

    E(0)<12(121p)(11p(p2)1ll)(B21)pp2  and  λ1<λ(0)=B21l||u0||22,

    are satisfied, then there exists T<+ such that

    limtT(||ut||22+||ut||22+||u||22+||u||p+p+)=+. (4.8)

    Proof. Assume by contradiction that (4.8) does not hold true, then for T<+ and all t[0,T], we get

    ||ut||22+||ut||22+||u||22+||u||p+p+C, (4.9)

    where C is a positive constant.

    Now, we define L(t) as follows:

    L(t)=H1α(t)+ϵΩutudx+ϵΩutudx, (4.10)

    where ε>0, small enough to be chosen later, and

    0αmin{pm+p(m+1),p22p}.

    The remaining proof will be divided into two steps.

    Step 1: Estimate for L'(t). By taking the derivative of (4.10) and using (1.1), we obtain

    L(t)=(1α)Hα(t)[Ω|ut|m(x)dx12(gu)+12g(t)||u||22]+ϵ||ut||22+ϵΩuttudx+ϵ||ut||22ϵ||u||22+ϵΩt0g(tτ)u(τ)dτudxϵΩ|ut|m(x)2utudx+ϵΩ|u|p(x)dxϵΩuttudx(1α)Hα(t)Ω|ut|m(x)dx+ϵ||ut||22ϵ||u||22+ϵΩt0g(tτ)u(τ)dτudxϵΩ|ut|m(x)2utudx+ϵΩ|u|p(x)dx+ϵ||Δut||22,

    applying Hölder's inequality and Young's inequality, we have

    ϵΩt0g(tτ)Δu(τ)Δu(t)dτdx=ϵΩt0g(tτ)Δu(t)(Δu(τ)Δu(t))dτdx+ϵt0g(tτ)dτ||Δu||22ϵt0g(tτ)||Δu(τ)Δu(t)||2||Δu(t)||2dτ+ϵt0g(tτ)dτ||Δu||22ϵp(1ε1)2(gu)+ϵ(112p(1ε1))t0g(τ)dτ||Δu||22,

    where 0<ε1<p2p, then

    L(t)(1α)Hα(t)Ω|ut|m(x)dx+ϵ||ut||22ϵ||Δu||22+ϵ||Δut||22ϵΩ|ut|m(x)2utudx+ϵΩ|u|p(x)dxϵp(1ε1)2(gu)+ϵ(112p(1ε1))t0g(τ)dτ||Δu||22,

    rewriting (4.7) to (p21)l12p(1l)>0, using (4.1) and (4.3) to substitute for (gu), choosing ε1>0 sufficiently small, we obtain

    L(t)(1α)Hα(t)Ω|ut|m(x)dx+ϵp(1ε1)H(t)+(ϵ+ϵp(1ε1)2)(||ut||22+||ut||22)+ϵ{(p(1ε1)21)(1t0g(τ)dτ)12p(1ε1)t0g(τ)dτ}||u||22ϵp(1ε1)E2ϵΩ|ut|m(x)2utudx+ϵε1Ω|u|p(x)dx(1α)Hα(t)Ω|ut|m(x)dx+ϵp(1ε1)H(t)+(ϵ+ϵp(1ε1)2)(||ut||22+||ut||22)+ϵ{(p(1ε1)21)l212p(1ε1)1l2}lλ2B21ϵp(1ε1)E2ϵΩ|ut|m(x)2utudx+ϵ{(p(1ε1)21)l212p(1ε1)1l2}||u||22+ϵε1Ω|u|p(x)dx.(1α)Hα(t)Ω|ut|m(x)dx+ϵp(1ε1)H(t)+(ϵ+ϵp(1ε1)2)(||ut||22+||ut||22)+ϵ{(p(1ε1)21)l212p(1ε1)1l2}l(B21)pp2ϵp(1ε1)E2ϵΩ|ut|m(x)2utudx+ϵ{(p(1ε1)21)l212p(1ε1)1l2}||u||22+ϵε1Ω|u|p(x)dx. (4.11)

    Step 1.1: Estimate for ϵ{(p(1ε1)21)l212p(1ε1)1l2}l(B21)pp2ϵp(1ε1)E2. It follows from the condition in Theorem 3.1 that

    E(0)<12(121p)(11lp(p2)l)(B21)pp2=(p21)l212p(1l)2lp(B21)pp2<E1,

    here, we can take ε1>0 sufficiently small and choose E2(E(0),E1) sufficiently close to E(0) such that

    ϵ(p(1ε1)21)l212p(1ε1)(1l)2l(B21)pp2ϵ(1ε1)pE2ϵ(p(1ε1)21)l212p(1ε1)(1l)2l(B21)pp2ϵ(1ε1)p(p21)l212p(1l)2lp(B21)pp20. (4.12)

    Therefore, we obtain by combining (4.11) and (4.12),

    L(t)(1α)Hα(t)Ω|ut|m(x)dx+ϵp(1ε1)H(t)+(ϵ+ϵp(1ε1)2)(||ut||22+||ut||22)+ϵε1Ω|u|p(x)dx+ϵ{(p(1ε1)21)l212p(1ε1)1l2}||u||22ϵΩ|ut|m(x)2utudx. (4.13)

    Step 1.2: Estimate for ϵΩ|ut|m(x)2utudx. Applying Young's inequality with ε2>1, the embedding Lp(x)(Ω)Lm(x)(Ω), Lemma 2.4 and Lemma 4.2, we easily have

    |Ω|ut|m(x)2utudx|Ω|ut|m(x)1Hαm(x)1m(x)(t)Hαm(x)1m(x)(t)|u|dxε2Hα(t)Ω|ut|m(x)dx+1εm12Ω|u|m(x)Hα(m(x)1)(t)dxε2Hα(t)Ω|ut|m(x)dx+2Cα(mm+)1εm12Hα(m+1)(t)Ω|u|m(x)dxε2Hα(t)Ω|ut|m(x)dx+C2εm12Hα(m+1)(t)max{||u||m+p(x),||u||mp(x)}, (4.14)

    where C1=min{H(0),1}, C2=2(1+|Ω|)m+Cα(mm+)1. Next, we have

    ||u||m+p(x)max{(Ω|u|p(x)dx)m+p+,(Ω|u|p(x)dx)m+p}max{[pH(t)]m+p+m+p,1}(Ω|u|p(x)dx)m+p,

    and

    ||u||mp(x)max{[pH(t)]mp+m+p,[pH(t)]mm+p}(Ω|u|p(x)dx)m+p,

    which illustrate

    max{||u||m+p(x),||u||mp(x)}C3(Ω|u|p(x)dx)m+p,

    where C3=2min{pH(0),1}mp+m+p. Recalling 0<αpm+p(m+1) and Lemma 4.2, apparently,

    Hα(m+1)(t)max{||u||m+p(x),||u||mp(x)}C3Hα(m+1)(t)(Ω|u|p(x)dx)m+pC3Hα(m+1)+m+p1(t)Hα(m+1)+m+p1(0)H1m+p(t)Hα(m+1)+m+p1(0)(Ω|u|p(x)dx)m+pC3(1p)1m+p(Ω|u|p(x)dx)1m+pHα(m+1)+m+p1(0)(Ω|u|p(x)dx)m+pC3(1p)1m+pCα(m+1)+m+p11Ω|u|p(x)dx, (4.15)

    it follows from (4.13), (4.14), and (4.15) that

    L(t)(1αϵε2)Hα(t)Ω|ut|m(x)dx+(ϵ+ϵp(1ε1)2)(||ut||22+||ut||22)+ϵ(1ε1)pH(t)+ϵ(ε1Cα(m+1)+m+p11C2C3(1p)1m+pεm12)Ω|u|p(x)dx+ϵ{(p(1ε1)21)l212p(1ε1)1l2}||u||22,

    let us fix the constant ε2 so that

    ε1>Cα(m+1)+m+p11C2C3(1p)1m+pεm12,

    and then choose ϵ so small that 1α>ϵε1. Therefore, we obtain

    L(t)M1(H(t)+||u||22+||ut||22+||ut||22+Ω|u|p(x)dx), (4.16)

    where

    M1=ϵmin{(1+p(1ε1)2),(1ε1)p,ε1Cα(m+1)+m+p11C2C3(1p)1m+pεm12,,(p(1ε1)21)l212p(1ε1)1l2}.

    Inequalities (4.16) and Lemma 4.2 imply L(t)L(0). Therefore, for a sufficiently small ϵ, we have

    L(0)=H1α(0)+ϵΩu1u0dx+ϵΩu1u0dx>0.

    Step 2: A differential inequality for L(t). Applying Hölder's inequality, Young's inequality and the embedding Lp(x)(Ω)L2(Ω), we easily obtain

    |Ωutudx|11α(ut2u2)11α(1+|Ω|)11α||ut||11α2||u||11αp(x)(1+|Ω|)11αμ||ut||11αμ2+(1+|Ω|)11αν||u||11ανp(x), (4.17)

    where 1μ+1ν=1. Choosing μ=2(1α)>1, then ν=2(1α)2(1α)1, further, (4.17) can be rewritten as

    |Ωutudx|11α(1+|Ω|)11αμ||ut||22+(1+|Ω|)11αν||u||22(1α)1p(x), (4.18)

    recalling 0<α<p22p, we obtain

    ||u||22(1α)1p(x)max{(Ω|u|p(x)dx)2p[2(1α)1],(Ω|u|p(x)dx)2p+[2(1α)1]}{[pH(t)]2p[2(1α)1]p[2(1α)1],[pH(t)]2p+[2(1α)1]p+[2(1α)1]}Ω|u|p(x)dxC4Ω|u|p(x)dx, (4.19)

    with C4=min{pH(0),1}2p+[2(1α)1]p+[2(1α)1]. Inserting (4.19) into (4.18), we obtain

    |Ωutudx|11α(1+|Ω|)11αμ||ut||22+(1+|Ω|)11ανC4Ω|u|p(x)dx. (4.20)

    We now estimate

    |Ωutudx|11α||ut||11α2||Δu||11α2C11αC11αH(0)H(t), (4.21)

    therefore, combining (4.20) and (4.21), we obtain

    L11α(t)=(H1α(t)+ϵΩutudx+ϵΩutudx)11αM2(H(t)+||ut||22+||ut||22+||u||22+Ω|u|p(x)dx), (4.22)

    where

    M2=max{211α(211α+ϵ11αC11αH(0)), 221αϵ11α(1+|Ω|)11αμ, 221αϵ11α(1+|Ω|)11ανC4}.

    Combining (4.16) and (4.22), we arrive at

    L(t)M1M2L11α(t),t0. (4.23)

    A simple integration of (4.23) over (0,t) yields

    Lα1α(t)1Lαα1(0)M1M2α1αt,

    this shows that L(t) blows up in finite time

    TM2M11ααLαα1(0),

    furthermore, one gets from (4.22) that

    limtT(H(t)+||ut||22+||ut||22+||u||22+Ω|u|p(x)dx)=+,

    it easily follows that

    Ω|u|p(x)dx{|u|1}|u|p+dx+{|u|<1}|u|pdx||u||p+p++|Ω|,

    and using Lemma 4.2, we obtain

    limtT(||ut||22+||ut||22+||u||22+||u||p+p+)=+,

    this leads to a contradiction with (4.9). Thus, the solution to Problem (1.1) blows up in finite time.

    Ying Chu: Methodology, Wring-original draft, Writing-review editing; Bo Wen and Libo Cheng: Methodology, Writing-original draft.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    The authors express their heartfelt thanks to the editors and referees who have provided some important suggestions. This work was supported by Science and Technology Development Plan Project of Jilin Province, China (20240101307JC).

    The authors declare there is no conflict of interest.

    [1] Folk JE (1983) Mechanism and basis for specificity of transglutaminase-catalyzed e-(g-glutamyl) lysine bond formation. Adv Enzymol Relat Areas Mol Biol 54: 1-56.
    [2] Lorand L, Conrad S M (1984) Transglutaminases. Mol Cell Biochem 58: 9-35. doi: 10.1007/BF00240602
    [3] Piacentini M, Martinet N, Beninati S, et al (1988) Free and protein conjugated-polyamines in mouse epidermal cells. Effect of high calcium and retinoic acid. J Biol Chem 263: 3790-3794 .
    [4] Song Y, Kirkpatrick LL, Schilling AB, et al. (2013) Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules. Neuron 78: 109-123. doi: 10.1016/j.neuron.2013.01.036
    [5] Achyuthan KE, Greenberg CS (1987) Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem 262: 1901-1906.
    [6] Hasegawa G, Suwa M, Ichikawa Y, et al. (2003) A novel function of tissue-type transglutaminase: protein disulfide isomerase. Biochem J 373: 793-803. doi: 10.1042/bj20021084
    [7] Lahav J, Karniel E, Bagoly Z, et al. (2009) Coagulation factor XIII serves as protein disulfide isomerase. Thromb Haemost 101: 840-844.
    [8] Iismaa SE, Mearns BM, Lorand L, et al (2009) Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 89: 991-1023. doi: 10.1152/physrev.00044.2008
    [9] Smethurst PA, Griffin M (1996) Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by calcium and nucleotides. Biochem J 313: 803-808. doi: 10.1042/bj3130803
    [10] Nakaoka H, Perez DM, Baek KJ, et al. (1994) Gh: a GTP-binding protein with transglutaminase activity and receptor signalling function. Science 264: 1593-1596.
    [11] Gentile V, Porta R, Chiosi E, et al (1997) Tissue transglutaminase and adenylate cyclase interactions in Balb-C 3T3 fibroblast membranes. Biochim Biophys Acta 1357: 115-122. doi: 10.1016/S0167-4889(97)00024-4
    [12] Nanda N, Iismaa SE, Owens WA, et al (2001) Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem 276: 20673-20678. doi: 10.1074/jbc.M010846200
    [13] Mian S, El Alaoui S, Lawry J, et al. (1995) The importance of the GTP binding protein tissue transglutaminase in the regulation of cell cycle progression. FEBS Letters 370: 27-31. doi: 10.1016/0014-5793(95)00782-5
    [14] Olaisen B, Gedde-Dahl TJR, Teisberg P, et al (1985) A structural locus for coagulation factor XIIIA (F13A) is located distal to the HLA region on chromosome 6p in man. Am J Hum Genet 37: 215-220.
    [15] Yamanishi K, Inazawa J, Liew FM, et al (1992) Structure of the gene for human transglutaminase 1. J Biol Chem 267: 17858-17863.
    [16] Gentile V, Davies PJA, Baldini A (1994) The human tissue transglutaminase gene maps on chromosome 20q12 by in situ fluorescence hybridization. Genomics 20: 295-297.
    [17] Wang M, Kim IG, Steinert PM, et al (1994) Assignment of the human transglutaminase 2 (TGM2) and transglutaminase 3 (TGM3) genes to chromosome 20q11.2. Genomics 23: 721-722. doi: 10.1006/geno.1994.1571
    [18] Gentile V, Grant F, Porta R, et al (1995) Human prostate transglutaminase is localized on chromosome 3p21.33-p22 by in situ fluorescence hybridization. Genomics 27: 219-220.
    [19] Grenard P, Bates MK, Aeschlimann D (2001) Evolution of transglutaminase genes: identification of a transglutaminases gene cluster on human chromosome 15q. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z. J Biol Chem 276: 33066-33078.
    [20] Thomas H, Beck K, Adamczyk M, et al (2013) Transglutaminase 6: a protein associated with central nervous system development and motor function. Amino Acids 44: 161-177. doi: 10.1007/s00726-011-1091-z
    [21] Bailey CDC, Johnson GVW (2004) Developmental regulation of tissue transglutaminase in the mouse forebrain. J Neurochem 91: 1369-1379. doi: 10.1111/j.1471-4159.2004.02825.x
    [22] Kim SY, Grant P, Lee JHC, et al (1999) Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminase 1 and 2 in Alzheimer’s disease. J Biol Chem 274: 30715-30721.
    [23] lannaccone M, Giuberti G, De Vivo G, et al (2013) Identification of a FXIIIA variant in human neuroblastoma cell lines. Int J Biochem Mol Biol 4: 102-107.
    [24] Citron BA, Santa Cruz KS, Davies PJ, et al (2001) Intron-exon swapping of transglutaminase mRNA and neuronal tau aggregation in Alzheimer’s disease. J Biol Chem 276: 3295-3301. doi: 10.1074/jbc.M004776200
    [25] De Laurenzi V, Melino G (2001) Gene disruption of tissue transglutaminase. Mol Cell Biol 21: 148-155.
    [26] Mastroberardino PG, Iannicola C, Nardacci R, et al (2002) ‘Tissue’ transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington’s disease. Cell Death Differ 9: 873-880.
    [27] Lorand L, Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nature Mol Cell Biol 4: 140-156. doi: 10.1038/nrm1014
    [28] Wolf J, Jäger C, Lachmann I, et al (2013) Tissue transglutaminase is not a biochemical marker for Alzheimer’s disease. Neurobiol Aging 34: 2495-2498. doi: 10.1016/j.neurobiolaging.2013.05.008
    [29] Wilhelmus MMM, Drukarch B (2014) Tissue transglutaminase is a biochemical marker for Alzheimer’s disease. Neurobiol Aging 35: 3-4.
    [30] Wolf J, Jäger C, Morawski M, et al. (2014) Tissue transglutaminase in Alzheimer’s disease—facts and fiction: a reply to “Tissue transglutaminase is a biochemical marker for Alzheimer’s disease”. Neurobiol Aging 35: 5-9.
    [31] Adams RD, Victor M (1993) Principles of Neurology. McGraw-Hill, Inc. Ed.
    [32] Selkoe DJ, Abraham C, Ihara Y (1982) Alzheimer’s disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. Proc Natl Acad Sci USA 79: 6070-6074. doi: 10.1073/pnas.79.19.6070
    [33] Grierson AJ, Johnson GV, Miller CC (2001) Three different human isoforms and rat neurofilament light, middle and heavy chain proteins are cellular substrates for transglutaminase. Neurosci Lett 298: 9-12. doi: 10.1016/S0304-3940(00)01714-6
    [34] Singer SM, Zainelli GM, Norlund MA, (2002) Transglutaminase bonds in neurofibrillary tangles and paired helical filament t early in Alzheimer’s disease. Neurochem Int 40: 17-30. doi: 10.1016/S0197-0186(01)00061-4
    [35] Halverson RA, Lewis J, Frausto S, et al (2005) Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice. J Neurosci 25: 1226-1233. doi: 10.1523/JNEUROSCI.3263-04.2005
    [36] Jeitner TM, Matson WR, Folk JE, et al (2008) Increased levels of g-glutamylamines in Huntington disease CSF. J Neurochem 106: 37-44. doi: 10.1111/j.1471-4159.2008.05350.x
    [37] Dudek SM, Johnson GV (1994) Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide. Brain Res 651: 129-133. doi: 10.1016/0006-8993(94)90688-2
    [38] Hartley DM, Zhao C, Speier AC, et al (2008) Transglutaminase induces protofibril-like amyloid b protein assemblies that are protease-resistant and inhibit long-term potentiation. J Biol Chem 283: 16790-16800. doi: 10.1074/jbc.M802215200
    [39] Citron BA, Suo Z, SantaCruz K, et al. (2002) Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration. Neurochem Int 40: 69-78. doi: 10.1016/S0197-0186(01)00062-6
    [40] Junn E, Ronchetti RD, Quezado MM, et al (2003) Tissue transglutaminase-induced aggregation of a-synuclein: Implications for Lewy body formation in Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 100: 2047-2052. doi: 10.1073/pnas.0438021100
    [41] Zemaitaitis MO, Lee JM, Troncoso JC, et al (2000) Transglutaminase-induced cross-linking of t proteins in progressive supranuclear palsy. J Neuropathol Exp Neurol 59: 983-989. doi: 10.1093/jnen/59.11.983
    [42] Zemaitaitis MO, Kim SY, Halverson RA, et al (2003) Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy. J Neuropathol Exp Neurol 62: 173-184. doi: 10.1093/jnen/62.2.173
    [43] Iuchi S, Hoffner G, Verbeke P, et al (2003) Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine. Proc Natl Acad Sci USA 100: 2409-2414. doi: 10.1073/pnas.0437660100
    [44] Gentile V, Sepe C, Calvani M, et al (1998) Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases. Arch Biochem Biophys 352: 314-321. doi: 10.1006/abbi.1998.0592
    [45] Kahlem P, Green H, Djian P (1998) Transglutaminase action imitates Huntington’s disease: selective polymerization of huntingtin containing expanded polyglutamine. Mol Cell 1: 595-601. doi: 10.1016/S1097-2765(00)80059-3
    [46] Karpuj MV, Garren H, Slunt H, et al (1999) Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington’s disease brain nuclei. Proc Natl Acad Sci USA 96: 7388-7393. doi: 10.1073/pnas.96.13.7388
    [47] Segers-Nolten IM, Wilhelmus MM, Veldhuis G, et al (2008) Tissue transglutaminase modulates a-synuclein oligomerization. Protein Sci 17: 1395-1402. doi: 10.1110/ps.036103.108
    [48] Lai TS, Tucker T, Burke JR, et al (2004) Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats. J Neurochem 88: 1253-1260. doi: 10.1046/j.1471-4159.2003.02249.x
    [49] Konno T, Mori T, Shimizu H, et al (2005) Paradoxical inhibition of protein aggregation and precipitation by transglutaminase-catalyzed intermolecular cross-linking. J Biol Chem 280: 17520-17525. doi: 10.1074/jbc.M413988200
    [50] The Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosome. Cell 72: 971-983. doi: 10.1016/0092-8674(93)90585-E
    [51] Banfi S, Chung MY, Jr KT, et al (1993) Mapping and cloning of the critical region for the spinocerebellar ataxia type 1 gene (SCA1) in a yeast artificial chromosome contig spanning 1.2 Mb. Genomics 18: 627-635. doi: 10.1016/S0888-7543(05)80365-9
    [52] Sanpei K, Takano H, Igarashi S, et al. (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 14: 277-284. doi: 10.1038/ng1196-277
    [53] Pujana MA, Volpini V, Estivill X (1998) Large CAG/CTG repeat templates produced by PCR, usefulness for the DIRECT method of cloning genes with CAG/CTG repeat expansions. Nucleic Acids Res 1: 1352-1353.
    [54] Fletcher CF, Lutz CM, O’Sullivan TN, et al (1996) Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87: 607-617. doi: 10.1016/S0092-8674(00)81381-1
    [55] Vincent JB, Neves-Pereira ML, Paterson AD, et al. (2000) An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: a common expansion locus. Am J Hum Genet 66: 819-829. doi: 10.1086/302803
    [56] Holmes SE, O’Hearn E, Margolis RL (2003) Why is SCA12 different from other SCAs? Cytogenet Genome Res 100: 189-197. doi: 10.1159/000072854
    [57] Imbert G, Trottier Y, Beckmann J, et al (1994) The gene for the TATA binding protein (TBP) that contains a highly polymorphic protein coding CAG repeat maps to 6q27. Genomics 21: 667-668. doi: 10.1006/geno.1994.1335
    [58] La Spada AR, Wilson EM, Lubahn DB, et al (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352: 77-79. doi: 10.1038/352077a0
    [59] Onodera O, Oyake M, Takano H, et al. (1995) Molecular cloning of a full-length cDNA for dentatorubral-pallidoluysian atrophy and regional expressions of the expanded alleles in the CNS. Am J Hum Genet 57: 1050-1060.
    [60] Cooper AJL, Sheu K-FR, Burke JR, et al. (1999) Pathogenesis of inclusion bodies in (CAG) n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability. J Neurochem 72: 889-899.
    [61] Hadjivassiliou M, Maki M, Sanders DS, et al (2006) Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology 66: 373-377.
    [62] Boscolo S, Lorenzon A, Sblattero D, et al. (2010) Anti transglutaminase antibodies cause ataxia in mice. Plos One 5: e9698. doi: 10.1371/journal.pone.0009698
    [63] Stamnaes J, Dorum S, Fleckenstein B, et al. (2010) Gluten T cell epitope targeting by TG3 and TG6; implications for dermatitis herpetiformis and gluten ataxia. Amino Acids 39: 1183-1191. doi: 10.1007/s00726-010-0554-y
    [64] Lerner A, Matthias T (2016) GUT-the Trojan horse in remote organs’ autoimmunity. J Clin Cell Immunol 7: 401.
    [65] Matthias T, Jeremias P, Neidhofer S, et al (2016) The industrial food additive microbial transglutaminase, mimics the tissue transglutaminase and is immunogenic in celiac disease patients. Autoimmun Rev DOI: 10.1016/j.autrev.2016.09.011.
    [66] Lerner A, Neidhofer S, Matthias T (2015) Transglutaminase 2 and anti transglutaminase 2 autoantibodies in celiac disease and beyond: Part A: TG2 double-edged sword: gut and extraintestinal involvement. Immunome Res 11: 101-105.
    [67] Wakshlag JJ, Antonyak MA, Boehm JE, et al (2006) Effects of tissue transglutaminase on beta-amyloid 1-42-induced apoptosis. Protein J 25: 83-94. doi: 10.1007/s10930-006-0009-1
    [68] Lee JH, Jeong J, Jeong EM, et al (2014) Endoplasmic reticulum stress activates transglutaminase 2 leading to protein aggregation. Int J Mol Med 33: 849-855.
    [69] Grosso H, Woo JM, Lee KW, et al (2014) Transglutaminase 2 exacerbates α-synuclein toxicity in mice and yeast. FASEB J 28: 4280-4291. doi: 10.1096/fj.14-251413
    [70] Zhang J, Wang S, Huang W, et al. (2016). Tissue transglutaminase and its product isopeptide are increased in Alzheimer’s disease and APPswe/PS1dE9 double transgenic mice brains. Mol Neurobiol 53: 5066-5078 doi: 10.1007/s12035-015-9413-x
    [71] Wilhelmus MM, De JM, Smit AB, et al (2016) Catalytically active tissue transglutaminase colocalises with Ab pathology in Alzheimer’s disease mouse models. Sci Rep DOI: 10.1038/srep20569.
    [72] Wilhelmus MMM, De JM, Rozemuller AJM, et al. (2012) Transglutaminase 1 and its regulator Tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies. J Pathol 226: 132-142. doi: 10.1002/path.2984
    [73] Basso M, Berlin J, Xia L, et al (2012) Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation. J Neurosci 39: 6561-6569.
    [74] Lee J, Kim YS, Choi DH, et al. (2004) Transglutaminase 2 induces nuclear factor-kB activation via a novel pathway in BV-2 microglia. J Biol Chem 279: 53725-53735. doi: 10.1074/jbc.M407627200
    [75] Kumar S, Mehta K (2012) Tissue transglutaminase constitutively activates HIF-1a promoter and nuclear factor-kB via a non-canonical pathway. Plos One. 7: e49321
    [76] Lu S, Saydak M, Gentile V, et al (1995) Isolation and characterization of the human tissue transglutaminase promoter. J Biol Chem 270: 9748-9755. doi: 10.1074/jbc.270.17.9748
    [77] Ientile R, Currò M and Caccamo D (2015) Transglutaminase 2 and neuroinflammation. Amino Acids 47: 19-26. doi: 10.1007/s00726-014-1864-2
    [78] Griffith OW, Larsson A, Meister A (1977) Inhibition of g-glutamylcysteine synthetase by cystamine: an approach to a therapy of 5-oxoprolinuria (pyroglutamic aciduria). Biochem Biophys Res Commun 79: 919-925.
    [79] Igarashi S, Koide R, Shimohata T, et al. (1998) Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet 18: 111-117. doi: 10.1038/ng0298-111
    [80] Karpuj MV, Becher MW, Springer JE, et al. (2002) Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat Med 8: 143-149.
    [81] Dedeoglu A, Kubilus JK, Jeitner TM, et al (2002) Therapeutic effects of cystamine in a murine model of Huntington’s disease. J Neurosci 22: 8942-8950.
    [82] Lesort M, Lee M, Tucholski J, et al (2003) Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders. J Biol Chem 278: 3825-3830.
    [83] Dubinsky R, Gray C (2006) CYTE-I-HD: Phase I dose finding and tolerability study of Cysteamine (Cystagon) in Huntington’s Disease. Movement Disord 21: 530-533. doi: 10.1002/mds.20756
    [84] Langman CB, Greenbaum LA, Sarwal M, et al (2012) A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety. Clin J Am Soc Nephrol 7: 1112-1120. doi: 10.2215/CJN.12321211
    [85] Besouw M, Masereeuw R, Van DHL, et al (2013) Cysteamine: an old drug with new potential. Drug Discov Today 18: 785-792. doi: 10.1016/j.drudis.2013.02.003
    [86] Hadjivassiliou M, Aeschlimann P, Strigun A, et al (2008) Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 64: 332-343. doi: 10.1002/ana.21450
    [87] Krasnikov BF, Kim SY, McConoughey SJ, et al (2005) Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondria. Biochemistry 44: 7830-7843. doi: 10.1021/bi0500877
    [88] Menalled LB, Kudwa AE, Oakeshott S, et al. (2014) Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6/2 and zQ175 mouse models of Huntington’s disease. Plos One 9: e99520-e99520. doi: 10.1371/journal.pone.0099520
    [89] Bailey CD, Johnson GV (2005) Tissue transglutaminase contributes to disease progression in the R6/2 Huntington’s disease mouse model via aggregate-independent mechanisms. J Neurochem 92: 83-92. doi: 10.1111/j.1471-4159.2004.02839.x
    [90] Davies JE, Rose C, Sarkar S, et al (2010) Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy. Sci Transl Med 2: 34-40.
    [91] Pietsch M, Wodtke R, Pietzsch J, et al (2013) Tissue transglutaminase: An emerging target for therapy and imaging. Bioorg Med Chem Lett 23: 6528-6543. doi: 10.1016/j.bmcl.2013.09.060
    [92] Bhatt MP, Lim YC, Hwang J, et al. (2013) C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activation. Diabetes 62: 243-253. doi: 10.2337/db12-0293
  • This article has been cited by:

    1. Tahir Boudjeriou, Ngo Tran Vu, Nguyen Van Thin, High Energy Blowup for a Class of Wave Equations With Critical Exponential Nonlinearity, 2025, 0170-4214, 10.1002/mma.10873
  • Reader Comments
  • © 2016 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(6136) PDF downloads(1145) Cited by(4)

Figures and Tables

Figures(4)  /  Tables(2)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog